rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2001-6-15
|
pubmed:abstractText |
Malignant fibrous histiocytoma (MFH) has been regarded as the most common soft tissue sarcoma (STS) in adults. Yet its true nature and the validity of this diagnostic concept have increasingly been questioned. Available data suggest that most patients with MFH can be subclassified into specific STS types, but the clinical relevance of such categorization has been argued. In a retrospective study, we reclassified 100 tumors of the extremity and trunk wall primarily diagnosed as MFH and analyzed the outcome.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0732-183X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3045-50
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11408500-Adult,
pubmed-meshheading:11408500-Aged,
pubmed-meshheading:11408500-Aged, 80 and over,
pubmed-meshheading:11408500-Disease-Free Survival,
pubmed-meshheading:11408500-Female,
pubmed-meshheading:11408500-Fibrosarcoma,
pubmed-meshheading:11408500-Histiocytoma, Benign Fibrous,
pubmed-meshheading:11408500-Humans,
pubmed-meshheading:11408500-Leiomyosarcoma,
pubmed-meshheading:11408500-Male,
pubmed-meshheading:11408500-Middle Aged,
pubmed-meshheading:11408500-Neoplasm Staging,
pubmed-meshheading:11408500-Prognosis,
pubmed-meshheading:11408500-Retrospective Studies,
pubmed-meshheading:11408500-Sarcoma,
pubmed-meshheading:11408500-Statistics, Nonparametric
|
pubmed:year |
2001
|
pubmed:articleTitle |
Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification.
|
pubmed:affiliation |
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article
|